Family · Pharmaceutical analytical standards
Eslicarbazepine
An antiepileptic closely related to oxcarbazepine, which makes neurons less excitable by acting on sodium channels. Approved in Europe in 2009 and in the United States in 2013 for partial-onset seizures. This family brings together the active ingredient.
Did you know?Developed in Portugal, it is given as the acetate, a prodrug: in the body it turns into eslicarbazepine so quickly that the parent molecule usually cannot even be detected in the blood.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
